Supn Lawsuit It is clear Court will not block Ranbaxy's filing of an ANDA to manufacture a generic version of Shire's Intuniv®
Shire LLC et al. v. Ranbaxy Inc. et al.
1:14-cv-00827; filed June 25, 2014 in the District Court of Delaware
• Plaintiffs: Shire LLC; Shire Development LLC; Supernus Pharmaceuticals Inc.
• Defendants: Ranbaxy Inc.; Ohm Laboratories Inc.; Ranbaxy Laboratories Ltd.
Infringement of U.S. Patent Nos. 6,287,599 ("Sustained Release Pharmaceutical Dosage Forms with Minimized pH Dependent Dissolution Profiles," issued September 11, 2001) and 6,811,794 (same title, issued November 2, 2004) based on Ranbaxy's filing of an ANDA to manufacture a generic version of Shire's Intuniv® (guanfacine, used to treat attention-deficit hyperactivity disorder). View the complaint here.